Abstract
RNA editing is an inflammatory modulator with high activity in the cardiovascular system. It is mainly active in noncoding genomic areas, but also invokes changes in coding genes, mimicking a mutation and altering protein function. Although RNA editing is implicated in atherosclerosis and cardiomyopathy, its role in atriopathy and AF is unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
